<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23499892</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>07</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7980</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>335</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Jul</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer letters</Title>
                <ISOAbbreviation>Cancer Lett</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Minnelide reduces tumor burden in preclinical models of osteosarcoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>412-20</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canlet.2013.02.050</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0304-3835(13)00213-9</ELocationID>
            <Abstract>
                <AbstractText>Osteosarcoma is the most common bone cancer in children and adolescents with a 5-year survival rate of about 70%. In this study, we have evaluated the preclinical therapeutic efficacy of the novel synthetic drug, Minnelide, a prodrug of triptolide on osteosarcoma. Triptolide was effective in significantly inducing apoptosis in all osteosarcoma cell lines tested but had no significant effect on the human osteoblast cells. Notably, Minnelide treatment significantly reduced tumor burden and lung metastasis in the orthotopic and lung colonization models. Triptolide/Minnelide effectively downregulated the levels of pro-survival proteins such as heat shock proteins, cMYC, survivin and targets the NF-κB pathway.</AbstractText>
                <CopyrightInformation>Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Banerjee</LastName>
                    <ForeName>Sulagna</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Basic and Translational Research, Department of Surgery, University of Minnesota, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thayanithy</LastName>
                    <ForeName>Venugopal</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sangwan</LastName>
                    <ForeName>Veena</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mackenzie</LastName>
                    <ForeName>Tiffany N</ForeName>
                    <Initials>TN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saluja</LastName>
                    <ForeName>Ashok K</ForeName>
                    <Initials>AK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Subramanian</LastName>
                    <ForeName>Subbaya</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 CA124723</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01CA124723</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01CA170496</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>03</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Cancer Lett</MedlineTA>
            <NlmUniqueID>7600053</NlmUniqueID>
            <ISSNLinking>0304-3835</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018906">Antineoplastic Agents, Alkylating</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C107489">BIRC5 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004224">Diterpenes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004852">Epoxy Compounds</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051034">Inhibitor of Apoptosis Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C489427">MYC protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010755">Organophosphates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010616">Phenanthrenes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016271">Proto-Oncogene Proteins c-myc</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000077022">Survivin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>19ALD1S53J</RegistryNumber>
                <NameOfSubstance UI="C001899">triptolide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>1CIV2UMO40</RegistryNumber>
                <NameOfSubstance UI="C579022">14-O-phosphonooxymethyltriptolide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.-</RegistryNumber>
                <NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.-</RegistryNumber>
                <NameOfSubstance UI="D053179">Caspase 7</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.-</RegistryNumber>
                <NameOfSubstance UI="D053453">Caspase 9</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018906" MajorTopicYN="N">Antineoplastic Agents, Alkylating</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053179" MajorTopicYN="N">Caspase 7</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053453" MajorTopicYN="N">Caspase 9</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004224" MajorTopicYN="N">Diterpenes</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004852" MajorTopicYN="N">Epoxy Compounds</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051034" MajorTopicYN="N">Inhibitor of Apoptosis Proteins</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009368" MajorTopicYN="N">Neoplasm Transplantation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010755" MajorTopicYN="N">Organophosphates</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010006" MajorTopicYN="N">Osteoblasts</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012516" MajorTopicYN="N">Osteosarcoma</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010616" MajorTopicYN="N">Phenanthrenes</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016271" MajorTopicYN="N">Proto-Oncogene Proteins c-myc</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077022" MajorTopicYN="N">Survivin</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047368" MajorTopicYN="N">Tumor Burden</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>01</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2013</Year>
                <Month>02</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>02</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23499892</ArticleId>
            <ArticleId IdType="pii">S0304-3835(13)00213-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.canlet.2013.02.050</ArticleId>
            <ArticleId IdType="pmc">PMC4386634</ArticleId>
            <ArticleId IdType="mid">NIHMS574437</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pathol Res Pract. 2000;196(10):665-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11087053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2012 Oct 17;4(156):156ra139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23076356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2002 Oct;2(4):323-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12398896</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1992 Jan;11(1):205-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1740106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Cell Biol. 1993 Jul-Aug;71(7-8):361-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7510113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci China B. 1994 May;37(5):557-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7917000</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol. 1996 Jan;270(1 Pt 2):F123-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8769830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 1997 Jul;17(7):4015-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9199336</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 1998 Oct;29(10):1050-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9781640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 1998 Nov 27;133(2):169-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10072166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1999 May 7;274(19):13443-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10224109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Biochem Sci. 2006 Mar;31(3):164-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16483782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Apr 7;281(14):9616-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16469748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes Dev. 2006 Jun 1;20(11):1394-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16751178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Appl Pharmacol. 2006 Oct 1;216(1):11-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16797629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2006 Dec;5(12):997-1014</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17139285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Cycle. 2006 Nov;5(22):2592-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17106261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 Jan 1;13(1):59-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17200339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Jan 15;67(2):616-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17234771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>DNA Cell Biol. 2007 Jan;26(1):1-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17263592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Joint Surg Am. 2007 Jun;89(6):1399-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17545444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Control. 2008 Jan;15(1):13-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18094657</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2008 Sep 18;268(2):212-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18471963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Drugs. 2008;10(5):315-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18754698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Invest. 2009 Mar;27(3):345-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19212829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leuk Lymphoma. 2009 May;50(5):802-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19330649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Surgery. 2009 Aug;146(2):282-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19628086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer. 2009;8:72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19735553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Metastasis. 2009;26(7):599-610</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19363654</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2010;10:241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20507646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2010 Sep;163(1):72-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20638672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2010 Oct;163(2):244-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20691980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Gene Ther. 2011 Apr;18(4):250-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21183950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biochem. 2011 May;112(5):1392-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21321991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2011 Jun 15;168(2):197-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19922946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G948-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21330448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol In Vitro. 2011 Dec;25(8):1796-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21964477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Oncol. 2012 Feb;40(2):409-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21947385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2012 May 16;104(10):749-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22534782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phytomedicine. 2012 Jun 15;19(8-9):756-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22464014</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2001 May 1;61(9):3750-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11325848</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
